Spots Global Cancer Trial Database for Exploring Biological Linkage Between Circadian Disruption and Cancer Progression
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Exploring Biological Linkage Between Circadian Disruption and Cancer Progression
Official Title: A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression
Study ID: NCT02011815
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.
Detailed Description: The biological markers that are assumed to bridge this association are measured and analyzed.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Contact Details
Name: Bong-Jin Hahm, M.D., Ph.D.
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
